TNDM

TANDEM DIABETES CARE INC

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1438133Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$1.02B

Net Income FY2025

$(0.21B)

EPS (Basic, as reported)

$-3.04

Net Margin FY2025

-20.2%

ROE FY2025

-131.9%

Total Equity

$0.16B

Shares Out

70M

Business description

TANDEM DIABETES CARE INC — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2012–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 84 → 1,015 +31.9% CAGR

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Revenue841081843624997038017489401,015

Cost of revenue(61)(64)(94)(168)(238)(327)(388)(380)(451)(469)

Gross profit244490194261376413368490546

Research & development(19)(21)(29)(45)(64)(92)————

Selling, general & administrative(83)(86)(105)(166)(205)(262)(336)(353)(390)(445)

Total operating expenses(102)(107)(134)(211)(268)(354)(506)(601)(589)(733)

Operating income(78)(63)(45)(17)(8)23(93)(233)(99)(187)

Interest expense——————(6)(10)(7)(8)

Other income (expense), net(5)(10)(78)(8)(28)(7)0137(13)

Pre-tax income(83)(73)(123)(25)(36)16(93)(220)(92)(200)

Income tax expense0000(2)0(2)(2)(4)(4)

Net income(83)(73)(123)(25)(34)16(95)(223)(96)(205)

EPS — basic———($0.42)($0.56)$0.25($1.47)($3.43)($1.47)($3.04)

EPS — diluted———($0.42)($0.56)$0.24($1.47)($3.43)($1.47)($3.04)

Shares outstanding — basic (M)———59616364656567

Shares outstanding — diluted (M)———59616464656567

Showing the latest 10 of 14 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.